NCT07124832 Intervention Study on Weight Loss in Patients With Obesity
| NCT ID | NCT07124832 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sıdıka Ece Yokuş |
| Condition | Obesity |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2025-08-14 |
| Primary Completion | 2025-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2025-08-14 with a primary completion date of 2025-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to evaluate the feasibility of using Socratic questioning as an alternative method for weight loss in adult patients with obesity (aged 18 to 65) in a primary care setting. The main question it aims to answer is: -Is Socratic questioning an effective alternative approach for promoting weight loss in patients with obesity? Researchers will compare participants receiving Socratic questioning during follow-up visits with those receiving regular care to see if the intervention leads to greater weight loss. Participants will: * Complete a baseline questionnaire including 9 demographic questions and the 14-item Hospital Anxiety and Depression Scale (approx. 5 minutes). * Attend five in-person follow-up visits with their family physician over a 3-month period (every 15 or 30 days), where they will receive brief counseling (10-15 minutes per visit) and have their weight, height, and waist circumference measured. * Complete a 17-question final questionnaire at the end of 3 months (approx. 10-15 minutes). * Be referred to mental health services if necessary, based on initial screening results.
Eligibility Criteria
Inclusion Criteria: * Age between 18 and 65 years * Body Mass Index (BMI) ≥ 30 kg/m² * Willingness to participate in the study Exclusion Criteria: * Pregnancy or breastfeeding * Presence of active psychosis or manic episode * Intellectual disability * Severe depression or personality disorder * Auto- or hetero-aggressive behavior * Reported use of psychoactive substances * Suicidal ideation * Participation in another weight loss program within the last 6 months * Use of medications that cause long-term weight gain or loss * Detection of psychopathology based on the Hospital Anxiety and Depression Scale (HADS)
Contact & Investigator
Raquel Gómez Bravo
STUDY DIRECTOR
Centre Hospitalier Neuro-Psychiatrique, Luxembourg
Frequently Asked Questions
Who can join the NCT07124832 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07124832 currently recruiting?
Yes, NCT07124832 is actively recruiting participants. Contact the research team at yokusece@gmail.com for enrollment information.
Where is the NCT07124832 trial being conducted?
This trial is being conducted at Manisa, Turkey (Türkiye).
Who is sponsoring the NCT07124832 clinical trial?
NCT07124832 is sponsored by Sıdıka Ece Yokuş. The principal investigator is Raquel Gómez Bravo at Centre Hospitalier Neuro-Psychiatrique, Luxembourg. The trial plans to enroll 36 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.